Logo image
Daratumumab monotherapy versus active monitoring in patients with high-risk smoldering multiple myeloma: AQUILA study outcomes
Conference proceeding   Peer reviewed

Daratumumab monotherapy versus active monitoring in patients with high-risk smoldering multiple myeloma: AQUILA study outcomes

Ross Baker
British journal of haematology, Vol.208(S1), pp.S239-S240
66th Annual Scientific Meeting of the British-Society-for-Hematology (BSH) (Liverpool, ENGLAND, 19/04/2026–21/04/2026)
04/2026

Details

Metrics

2 Record Views
Logo image